BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31072504)

  • 21. Validating Utility of Dual Antiplatelet Therapy Score in a Large Pooled Cohort From 3 Japanese Percutaneous Coronary Intervention Studies.
    Yoshikawa Y; Shiomi H; Watanabe H; Natsuaki M; Kondo H; Tamura T; Nakagawa Y; Morimoto T; Kimura T
    Circulation; 2018 Feb; 137(6):551-562. PubMed ID: 28982692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Intravascular Ultrasound-Guided Versus Angiography-Guided New-Generation Drug-Eluting Stent Implantation: Meta-Analysis With Individual Patient-Level Data From 2,345 Randomized Patients.
    Shin DH; Hong SJ; Mintz GS; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    JACC Cardiovasc Interv; 2016 Nov; 9(21):2232-2239. PubMed ID: 27744039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents.
    Yu J; Baber U; Mastoris I; Dangas G; Sartori S; Steg PG; Cohen DJ; Giustino G; Chandrasekhar J; Ariti C; Witzenbichler B; Henry TD; Kini AS; Krucoff MW; Gibson CM; Chieffo A; Moliterno DJ; Colombo A; Pocock S; Mehran R
    JACC Cardiovasc Interv; 2016 Jul; 9(14):1461-9. PubMed ID: 27478113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcome of titanium-nitride-oxide-coated cobalt-chromium stents in patients with de novo coronary lesions: 12-month results of the OPTIMAX first-in-man study.
    Karjalainen PP; Mikkelsson J; Paana T; Nammas W
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):E122-7. PubMed ID: 26308878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
    Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Meta-analysis of randomized controlled trials comparing percutaneous coronary intervention with aspiration thrombectomy Vs. Conventional percutaneous coronary intervention during ST-segment elevation myocardial infarction.
    Dominguez AC; Bittl JA; El-Hayek G; Contreras E; Tamis-Holland JE
    Catheter Cardiovasc Interv; 2016 Jun; 87(7):1203-10. PubMed ID: 26699698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bare-metal stent versus drug-eluting stent in large coronary arteries: meta-analysis of randomized controlled trials.
    Geng DF; Meng Z; Yan HY; Nie RQ; Deng J; Wang JF
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1087-94. PubMed ID: 22899538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention: The ADAPT-DES Study.
    Brener SJ; Kirtane AJ; Stuckey TD; Witzenbichler B; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Mehran R; Parvataneni R; Brodie BR; Stone GW
    JACC Cardiovasc Interv; 2016 Jul; 9(14):1450-7. PubMed ID: 27372190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential 1-year clinical outcomes for ST-segment elevation myocardial infarction related to stent thrombosis or saphenous vein graft thrombosis.
    Arzamendi D; Ly HQ; Tanguay JF; Armero S; Jilaihawi H; Gallo R; Ibrahim R; L'Allier P; Blondeau L; Gosselin G; Gregoire J; Doucet S
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):193-200. PubMed ID: 21805615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Diabetes Mellitus in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.
    Baber U; Stefanini GG; Giustino G; Stone GW; Leon MB; Sartori S; Aquino M; Steg PG; Windecker S; Wijns W; Serruys PW; Valgimigli M; Morice MC; Camenzind E; Weisz G; Smits PC; Kandzari DE; von Birgelen C; Dangas GD; Galatius S; Jeger RV; Kimura T; Mikhail GW; Itchhaporia D; Mehta L; Ortega R; Kim HS; Kastrati A; Chieffo A; Mehran R
    Circ Cardiovasc Interv; 2019 Jul; 12(7):e007734. PubMed ID: 31288561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials.
    Ndrepepa G; Neumann FJ; Deliargyris EN; Mehran R; Mehilli J; Ferenc M; Schulz S; Schömig A; Kastrati A; Stone GW
    Circ Cardiovasc Interv; 2012 Oct; 5(5):705-12. PubMed ID: 23048052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bleeding Severity After Percutaneous Coronary Intervention.
    Redfors B; Généreux P; Witzenbichler B; Kirtane AJ; McAndrew T; Weisz G; Stuckey TD; Henry TD; Maehara A; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e005542. PubMed ID: 29870382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents.
    Maehara A; Mintz GS; Witzenbichler B; Weisz G; Neumann FJ; Rinaldi MJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Brodie BR; Stuckey TD; Mazzaferri EL; McAndrew T; Généreux P; Mehran R; Kirtane AJ; Stone GW
    Circ Cardiovasc Interv; 2018 Nov; 11(11):e006243. PubMed ID: 30571206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlates and outcomes of late and very late drug-eluting stent thrombosis: results from DESERT (International Drug-Eluting Stent Event Registry of Thrombosis).
    Waksman R; Kirtane AJ; Torguson R; Cohen DJ; Ryan T; Räber L; Applegate R; Waxman S; Gordon P; Kaneshige K; Leon MB;
    JACC Cardiovasc Interv; 2014 Oct; 7(10):1093-102. PubMed ID: 25240540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety and effectiveness of bivalirudin in female patients with acute myocardial infarction undergoing primary angioplasty: A subgroup analysis of the BRIGHT trial.
    Liang Z; Li Y; Wang J; Wang D; Wang S; Ma L; Liu H; Yang L; Stone GW; Han Y
    Catheter Cardiovasc Interv; 2016 Mar; 87 Suppl 1():608-15. PubMed ID: 26762481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rationale, Design, and Baseline Characteristics of the Prospective Japan Acute Myocardial Infarction Registry (JAMIR).
    Honda S; Nishihira K; Kojima S; Takegami M; Asaumi Y; Suzuki M; Kosuge M; Takahashi J; Sakata Y; Takayama M; Sumiyoshi T; Ogawa H; Kimura K; Yasuda S;
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):97-103. PubMed ID: 30470946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Central Adjudication Identified Additional and Prognostically Important Myocardial Infarctions in Patients Undergoing Percutaneous Coronary Intervention.
    Olivier CB; Bhatt DL; Leonardi S; Stone GW; Gibson CM; Steg PG; Hamm CW; Wilson MD; Mangum S; Price MJ; Prats J; White HD; Lopes RD; Harrington RA; Mahaffey KW;
    Circ Cardiovasc Interv; 2019 Jul; 12(7):e007342. PubMed ID: 31296081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of in-hospital bleeding according to the Bleeding Academic Research Consortium classification on the long-term adverse outcomes in patients undergoing percutaneous coronary intervention.
    Yoon YH; Kim YH; Kim SO; Lee JY; Park DW; Kang SJ; Lee SW; Lee CW; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):63-71. PubMed ID: 24282105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiographic and clinical performance of polymer-free biolimus-eluting stent in patients with ST-segment elevation acute myocardial infarction in a metropolitan public hospital: The BESAMI MUCHO study.
    Sgueglia GA; D'Errico F; Gioffrè G; De Santis A; Summaria F; Piccioni F; Gaspardone A
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):851-858. PubMed ID: 28766881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.